Vistim Labs Closes First Round of Funding
May 11, 2023
Altitude Lab recently announced that Vistim Labs, one of their current first year companies, has successfully closed its seed round, oversubscribed at $800,000. According to Altitude’s report, completing this round will finance Vistim’s go-to-market this year and allow them to raise another $2M this fall to scale their sales in 2024.
Recent News
- BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies
- KyphoLift Debuts at ISMRM 2025: Transforming Patient Positioning for Safer, More Accurate Imaging
- Kelvyn Cullimore: An Unfair Penalty on Life-Saving Pills
- Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis
- Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial
- Myriad Genetics Announces RiskScore Study Published in JCO Precision Oncology
